Axonics Modulation Technologies, Inc. (AXNX)
Chart Events
Performance Outlook
| Previous Close | 43.64 |
| Open | 44.11 |
| Bid | 45.46 x 1200 |
| Ask | 45.58 x 900 |
| Day's Range | 43.36 - 45.80 |
| 52 Week Range | 15.25 - 52.10 |
| Volume | 121,976 |
| Avg. Volume | 571,065 |
| Market Cap | 1.805B |
| Beta (5Y Monthly) | 0.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.90 |
| Earnings Date | Nov 04, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 61.00 |
Fair Value
Related Research
- Business Wire
Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on December 1-2, 2020.
- Business Wire
Axonics® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM® System
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced the publication of fecal incontinence study results for patients treated with the Axonics r-SNM System.
- Simply Wall St.
Axonics Modulation Technologies, Inc.'s (NASDAQ:AXNX) Intrinsic Value Is Potentially 54% Above Its Share Price
Today we will run through one way of estimating the intrinsic value of Axonics Modulation Technologies, Inc...
